Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Mylan to infuse USD 1 billion on capex in India

      Mylan to infuse USD 1 billion on capex in India

      Medical Dialogues Bureau30 Sept 2019 9:30 AM IST
      Mylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
      Biocon chief Kiran Shaw vows to cut cost of rh-Insulin

      Biocon chief Kiran Shaw vows to cut cost of rh-Insulin

      Medical Dialogues Bureau29 Sept 2019 10:00 AM IST
      New Delhi: Biocon Chief, Kiran Mazumdar-Shaw, Philanthropist and Founder of Biocon, recently, announced her personal commitment towards enabling...
      OncoStem Diagnostics named

      OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and healthcare innovation forum

      Medical Dialogues Bureau29 Sept 2019 9:57 AM IST
      Bangalore, : OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment was named as 'Best Innovation- Cancer Risk...
      Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain

      Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain

      Medical Dialogues Bureau29 Sept 2019 9:55 AM IST
      Proclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...
      Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

      Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

      Medical Dialogues Bureau28 Sept 2019 2:38 PM IST
      "Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
      A Vaidheesh re-elected President of OPPI for the third consecutive year

      A Vaidheesh re-elected President of OPPI for the third consecutive year

      Medical Dialogues Bureau28 Sept 2019 10:26 AM IST
      A. Vaidheesh, Vice President, South Asia & Managing Director, GlaxoSmithKline Pharmaceuticals Ltd. has been re-elected as the President for OPPI,...
      Eisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in India

      Eisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in India

      Medical Dialogues Bureau28 Sept 2019 9:57 AM IST
      New Delhi- Eisai Pharmaceuticals India Pvt. Ltd and Mylan Pharmaceuticals Pvt Ltd. (Mylan), jointly announced that they have entered into a marketing...
      Zydus receives final approval from USFDA for Clobetasol Propionate Lotion

      Zydus receives final approval from USFDA for Clobetasol Propionate Lotion

      Medical Dialogues Bureau28 Sept 2019 9:02 AM IST
      New Delhi: Zydus Cadila has received the final approval from the USFDA to market Clobetasol Propionate Lotion, (US RLD - Clobex Lotion),...
      Cipla launches skin treatment Daptomycin Injection in US

      Cipla launches skin treatment Daptomycin Injection in US

      Medical Dialogues Bureau27 Sept 2019 1:53 PM IST
      Drug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
      Fraud: SEBI bars Morepen from market for 1 year

      Fraud: SEBI bars Morepen from market for 1 year

      Medical Dialogues Bureau27 Sept 2019 1:44 PM IST
      New Delhi: Capital markets regulator SEBI on Tuesday barred Morepen Laboratories from the capital markets for one year for making misleading...
      AstraZeneca India bags DCGI  marketing nod for QTERN-once-daily anti-diabetes drug

      AstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drug

      Medical Dialogues Bureau27 Sept 2019 11:54 AM IST
      26 September 2019: AstraZeneca Pharma India Limited (AstraZeneca India) announced that it has received Import & Market permission for QTERN®...
      Strides Pharma suspends sale of Ranitidine tab in US

      Strides Pharma suspends sale of Ranitidine tab in US

      Medical Dialogues Bureau27 Sept 2019 9:56 AM IST
      New Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok